Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • 4015-16: Responding to the IOM (2015) Report on Psychosocial Interventions: Application of the Perspectives of Psychiatry

    Contains 5 Component(s), 0.75 credits offered

    Presenters: Karan S. Kverno, PhD, PMHNP-BC, PMHCNS-BC; Tamar U. Rodney, MSN, PMHNP-BC 0.75 contact hours

    4015-16:  Responding to the IOM (2015) Report on Psychosocial Interventions:  Application of the Perspectives of Psychiatry

    This presentation provides an introduction to the Perspectives of Psychiatry and how they provide a rational approach to person-centered care.  It will discuss ways that psychiatric mental health nurses can lead initiatives to identify key elements of evidence-based psychotherapeutic interventions and develop improved standards of care.

    Presenters: Karan S. Kverno, PhD, PMHNP-BC, PMHCNS-BC; Tamar U. Rodney, MSN, PMHNP-BC

    Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation. 

    Session Length:  46 minutes

    Target Audience:  APRN

    Session Objectives
    Upon completion of this presentation, the participant will be able to:

    1. Describe the Perspectives of Psychiatry.
    2. Discuss recommendations of the IOM (2015) report on psychosocial interventions for mental and substance use disorders.
    3. Utilize the Perspectives of Psychiatry to match elements of evidence-based psychotherapeutic interventions to the needs of individual patients.


    Keywords:
    IOM Interventions, Four Perspecitves of Psychiatry, Psychosocial Intervention Concepts, H.I.D.E. 

    Continuing Nursing Education
    0.75 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. 

    Originally Presented
    APNA 30th Annual Conference
    Hartford, Connecticut
    Saturday, October 22
    10:15am - 11:00am

    Release Date: February 21, 2017
    The contact hours for this session expire:  November 30, 2019


     

  • Effective Treatments for Opioid Use Disorder: Educating & Empowering All Registered Nurses (RN) During an Epidemic

    Contains 7 Component(s), 1.25 credits offered

    This continuing educational activity was developed by the American Psychiatric Nurses Association to provide education to all nurses regarding epidemic opioid use in the U.S. and to answer the question, “What can nurses do?” to address this growing problem. Almost 4 million nurses can make a difference!

    Effective Treatments for Opioid Use Disorder: Educating & Empowering All Registered Nurses (RN) During an Epidemic

    This continuing educational activity was developed by the American Psychiatric Nurses Association to provide education to all nurses regarding the epidemic of opioid use in the U.S. and to answer the question, 
    “What can nurses do?” to address this growing problem.

    Almost 4 million nurses can make a difference!


    Effective Treatments for Opioid Use Disorder: Educating & Empowering All Registered Nurses (RN) During an Epidemic


    Presenters:

    Carolyn Baird, DNP, MBA, RN-BC, CARN-AP, CCDPD, FIAAN
    Mary Kastner, PMHNP-BC

    Target Audience: RN

    Contact hours: 1.25


    Goals of the Program: To Empower Nurses to Address the Opioid Epidemic Through:

    • Increasing competence
    • Making work more meaningful
    • Fostering motivation to effect change
    • Transitioning from stigma to recovery

    Webinar content includes: 

    • Summary of Epidemiology
    • Introduction to treatment (Strengths-based approach)
    • Psychosocial Therapies Medications (methadone/buprenorphine/naltrexone – naloxone for emergency)
    • Psychosocial treatment combined with medication assisted treatment

    What nurses can do:

    • Individualize care: meet patient where they are
    • Be aware of most effective treatments
    • Educate patients and others
    • Advocate for access to a range of effective interventions
    • Critically evaluate research
    • Initiate research

    Pricing: Free

    Continuing Nursing Education 
    1.25 contact hours. * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed. 

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. 


    Release Date: July 15, 2016
    The contact hours for this session expire: December 15, 2018

  • Effective Treatments for Opioid Use Disorder: Educating & Empowering Psychiatric Mental-Health Nurses (PMH-RN) During an Epidemic

    Contains 7 Component(s), 1.25 credits offered

    This continuing educational activity was developed by the American Psychiatric Nurses Association to provide education to all nurses regarding epidemic opioid use in the U.S. and to answer the question, “What can nurses do?” to address this growing problem. Almost 4 million nurses can make a difference!

    Effective Treatments for Opioid Use Disorder: Educating & Empowering Psychiatric Mental-Health Nurses (PMH-RN) During an Epidemic

    This continuing educational activity was developed by the American Psychiatric Nurses Association to provide education to all nurses regarding the epidemic of opioid use in the U.S. and to answer the question, 
    “What can nurses do?” to address this growing problem.

    Almost 4 million nurses can make a difference!


    Effective Treatments for Opioid Use Disorder: Educating & Empowering Psychiatric Mental-Health Nurses (PMH-RN) During an Epidemic

    Presenter: Laura Leahy, DrNP, APRN, PMH-CNS/FNP, BC

    Target Audience: Psychiatric-Mental Health Nurses (PMH-RNs) 

    Contact hours: 1.25


    Goals of the Program: To Empower Nurses to Address the Opioid Epidemic Through:

    •  Increasing competence
    •  Making work more meaningful 
    •  Fostering motivation to effect change
    •  Transitioning language from stigma to recovery

    Webinar content includes: 

    •  Summary of Epidemiology - Introduction to treatment (Strengths-based approach)
    •  Psychosocial Therapies
    •  Medications (methadone/buprenorphine/naltrexone – naloxone for emergency)
    •  Psychosocial treatment combined with medication assisted treatment

    What nurses can do:

    •  Individualize care: meet patient where they are
    •  Be aware of most effective treatments
    •  Educate patients and others
    •  Advocate for access to a range of effective interventions
    •  Critically evaluate research
    •  Initiate research

    Pricing: Free

    Continuing Nursing Education 
    1.25 contact hours. * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed. 

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. 


    Release Date: July 15, 2016
    The contact hours for this session expire: December 15, 2018

  • 1014-16: T-3 + T-4: Do You Know Your Patient's Score? The Role of Thyroid Hormones in the Management of Depression

    Contains 5 Component(s), 1.50 credits offered

    Presenter: Mary D. Moller, DNP, ARNP, APRN, PMHCNS-BC, CPRP, FAAN 1.5 contact hours

    1014-16: T-3 + T-4: Do You Know Your Patient’s Score? The Role of Thyroid Hormones in the Management of Depression

    Participants will acquire the knowledge, skills, and abilities to assess, diagnose, and pharmacologically manage co-morbid hypothyroidism in patients with both unipolar and bipolar disorders.

    Presenter: Mary D. Moller, DNP, ARNP, APRN, PMHCNS-BC, CPRP, FAAN

    Disclosures: The speaker has indicated a significant financial interest or other affiliation with Speaker's Bureau for Alkermes Pharmaceutical.  Off-label uses will not be discussed during this presentation. The activity planners have no conflicts of interest to disclose.

    Session Length:  90 minutes

    Target Audience:  RN, APRN

    Session Objectives:
    Upon completion of this presentation, the participant will be able to:

    1. Review the physiology of thyroid hormone formation and relationship to the HYPAC and exacerbation of depressive symptoms.  2. Differentiate physical and psychiatric assessment findings specific to thyroid function.
    3. Interpret laboratory tests associated with evaluation of the thyroid gland and implications for treatment.
    4. Discuss formulations, dosing strategies, and drug interactions related to augmentation, supplementation, and replacement of thyroid hormones.

    Keywords: Thyroid, Hormones, Psychopharmacology, Bipolar Disorder, Depression

    Continuing Nursing Education 1.5 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The content of this CNE activity pertains to pharmacology.  Because states' requirements may vary, contact your Board of Nursing for more information.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Originally Presented
    APNA 14th Annual Clinical Psychopharmacology Institute
    Hyatt Regency Baltimore on the Inner Harbor
    Sunday, June 12, 2016 12:15pm – 1:45pm

    Release Date:  July 29, 2016
    The contact hours for this session expire: September 1, 2019

     

  • 1008-16: Treating Opioid Use Disorder During the Current Epidemic

    Contains 5 Component(s), 1.50 credits offered

    Presenter: Matthew Tierney, APN-BC, PMHNP-BC 1.5 contact hours

    1008-16: Treating Opioid Use Disorder During the Current Epidemic

    The purpose of this activity is to empower nurses to provide and/or support patient access to evidence-based treatments for opioid use disorders.

    Presenter: Matthew Tierney, APN-BC, PMHNP-BC

    Disclosures: The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will be discussed during this presentation.

    Session Length:  90 minutes

    Target Audience:  RN, APRN

    Session Objectives:
    Upon completion of this presentation, the participant will be able to:
    1. Summarize epidemiologic research details on current rates of opioid use, related morbidity and mortality, and impediments to treatment.
    2. Identify pharmacologic treatment options for patients with opioid use disorders, and select the best treatment option/s based on patient needs
    3. Define at least one way to increase access to treatment for opioid use disorders in the setting(s) or communities where you work as a psychiatric nurse.

    Keywords: Opioid, Addiction, Evidence Based Treatments, Opioid Use Disorders, Nursing Practice

    Continuing Nursing Education
    1.5 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Originally Presented
    APNA 14th Annual Clinical Psychopharmacology Institute
    Hyatt Regency Baltimore on the Inner Harbor
    Saturday, June 11, 2016
    9:45am – 11:15am

    Release Date: July 29, 2016
    The contact hours for this session expire: September 1, 2019

  • 1013-16: Tobacco Dependence Treatment: Neurobiology through Public Policy

    Contains 5 Component(s), 1.25 credits offered

    Presenter: Mary Ellen Wewers, PhD, RN 1.25 contact hours

    1013-16: Tobacco Dependence Treatment: Neurobiology through Public Policy

    This session will discuss the prevalence of tobacco use and tobacco control efforts among groups with psychiatric mental health diagnoses. The major approaches to reducing the burden of tobacco that involve prevention, behavioral interventions, pharmacologic interventions and policy-based control methods will be described.

    Presenter: Mary Ellen Wewers, PhD, RN

    Disclosures: The speaker has indicated a significant financial interest or other affiliation with NIH funding.  Off-label uses will not be discussed during this presentation. The activity planners have no conflicts of interest to disclose.

    Session Length: 80 minutes

    Target Audience: RN, APRN

    Session Objectives:
    Upon completion of this presentation, the participant will be able to:
    1. To describe prevalence of tobacco use among patients with mental illness.
    2. To characterize a new theory about the neurobiology of nicotine addiction.
    3. To describe evidence-based clinical interventions for tobacco dependence treatment for patients/clients with mental illness.
    4. To discuss policy level tobacco control interventions for implementation in health care settings and communities.

    Keywords: Tobacco

    Continuing Nursing Education
    1.25 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The content of this CNE activity pertains to pharmacology. Because states' requirements may vary, contact your Board of Nursing for more information.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Originally Presented
    APNA 14th Annual Clinical Psychopharmacology Institute
    Hyatt Regency Baltimore on the Inner Harbor
    Sunday, June 11, 2016
    9:45am – 11:15am

    Release Date: July 29, 2016 
    The contact hours for this session expire: September 1, 2019

  • 1005-16: Military Psychiatry: Practice and Pitfalls for Civilian Providers

    Contains 5 Component(s), 1.50 credits offered

    Presenter: Joseph Holshoe, MSN, PMHNP-BC 1.5 contact hours

    1005-16: Military Psychiatry: Practice and Pitfalls for Civilian Providers

    Joe Holshoe uses his experience as a Navy officer and now US Public Health service officer to provide a detailed description of military medicine. He includes medications and diagnoses that can prevent enlistment and/or deployment in a discussion related to treatment of military members.

    Presenter: Joseph Holshoe, MSN, PMHNP-BC

    Disclosures: The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will be discussed during this presentation.

    Session Length: 90 minutes

    Target Audience: RN, APRN

    Session Objectives:
    Upon completion of this presentation, the participant will be able to:
    1. Review the basic structure of military hierarchy and medicine.
    2. Explore the dual nature of military medicine.
    3. Identify medications that can limit deployment.
    4. Identify diagnoses that can prevent enlistment and deployments.
    5. Discuss variances in psychiatric presentation in military populations.

    Keywords: Military, Psychopharmacology, Medications, Deployment

    Continuing Nursing Education
    1.5 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Originally Presented
    APNA 14th Annual Clinical Psychopharmacology Institute
    Hyatt Regency Baltimore on the Inner Harbor
    Friday, June 10, 2016
    1:45pm – 3:15pm

    Release Date:  July 29, 2016
    The contact hours for this session expire: September 1, 2019

  • 1006-16: Assessment and Treatment of Transgender and Gender Expansive Youth

    Contains 5 Component(s), 1.25 credits offered

    Presenter: Valerie Tobin, MS, PMHNP, PMHCNS-BC 1.25 pharmacology contact hours

    1006-16: Assessment and Treatment of Transgender and Gender Expansive Youth

    Enhance the knowledge and skill of PMH nurses to care for young persons who are transgender and gender expansive.

    Presenter: Valerie Tobin, MS, PMHNP, PMHCNS-BC

    Disclosures: The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will be discussed during this presentation.

    Session Length:  90 minutes

    Target Audience:  RN, APRN

    Session Objectives:
    Upon completion of this presentation, the participant will be able to:
    1. Describe gender identity.
    2. Recognize health risks for this population.
    3. Examine the Standards of Care developed by World Professional Association for Transgender Health.
    4. Develop a plan of care that differentiates between children and adolescents.
    5. Counsel a transgender patient about the risks and benefits of hormone treatments.

    Keywords: Transgender, LGBT, Adolescents, Children, Health Risks, Standards of Care

    Continuing Nursing Education
    1.25 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Originally Presented
    APNA 14th Annual Clinical Psychopharmacology Institute
    Hyatt Regency Baltimore on the Inner Harbor
    Friday, June 10, 2016
    3:30pm – 5:00pm

    Release Date: July 29, 2016
    The contact hours for this session expire: November 30, 2019

  • 1002-16: Pharmacologic Treatment of Schizophrenia: How Far Have We Come?

    Contains 5 Component(s), 1.50 credits offered

    Presenter: John M. Kane, MD 1.5 contact hours

    1002-16: Pharmacologic Treatment of Schizophrenia: How Far Have We Come?

    This dynamic presentation will increase your knowledge of evidence based treatment decisions for persons diagnosed with Schizophrenia. Dr. Kane provides an overview of the comprehensive specialty care needed for first episode patients. He describes evidence based treatment methods that will assist in increased numbers of patients consistently taking their medications and living healthier lives.

    Presenter: John M. Kane, MD

    Disclosures: The speaker has indicated a significant financial interest or other affiliation with Honorarium or Consultant for Alkermes, Forum, Intra Cellular Therapies, Janssen, Lundbeck, Otsuka, Sunovion, Teva, Reviva. Shareholder in Medavante, Vanguard, LB Pharma.  Off-label uses will not be discussed during this presentation. The activity planners have no conflicts of interest to disclose.

    Session Length:  90 minutes

    Target Audience:  RN, APRN

    Session Objectives:
    Upon completion of this presentation, the participant will be able to:

    1. Increase understanding of comprehensive specialty care in first episode patients.
    2. Increase knowledge of issues surrounding adherence in medication-taking.
    3. Increase knowledge of long acting injectable and psychotics.
    4. Increase knowledge of clozapine indications and use.

    Keywords: Schizophrenia, Evidence based treatment, Medications, Long acting injectibles

    Continuing Nursing Education
    1.5 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The content of this CNE activity pertains to pharmacology.  Because states' requirements may vary, contact your Board of Nursing for more information.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Originally Presented
    APNA 14th Annual Clinical Psychopharmacology Institute
    Hyatt Regency Baltimore on the Inner Harbor
    Friday, June 10, 2016
    8:00am - 9:30am

    Release Date:  July 29, 2016
    The contact hours for this session expire: September 1, 2019

  • 1001-16: Benzodiazepines: Boon or Boondoggle and Counteraction

    Contains 5 Component(s), 2.00 credits offered

    Presenter: Barbara Limandri, PhD, PMHNP, BC 2.0 contact hours

    1001-16: Benzodiazepines: Boon or Boondoggle and Counteraction

    An in-depth look at the pharmacokinetics and pharmacodynamics of benzodiazapines. Everything you need to develop knowledge and skill in assisting clients to withdraw from long-term use of benzodiazepines.

    Presenter: Barbara Limandri, PhD, PMHNP, BC

    Disclosures: The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation.

    Session Length:  1 Hour 45 minutes

    Target Audience:  RN, APRN

    Session Objectives:
    Upon completion of this presentation, the participant will be able to:
    1. Explain the issues of prescribing patterns of benzodiazepines in the United States.
    2. Review the mechanisms of action of benzodiazepines in relation to treatment outcomes.
    3. Discuss protocols for benzodiazepine withdrawal and discontinuation.

    Keywords: Benzodiazepines, Psychopharmacology, Protocols for Benzodiazepine Withdrawls

    Continuing Nursing Education
    2.0 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Originally Presented
    APNA 14th Annual Clinical Psychopharmacology Institute
    Hyatt Regency Baltimore on the Inner Harbor
    Thursday, June 9, 2016
    5:00pm – 7:00pm

    Release Date: July 29, 2016
    The contact hours for this session expire: September 1, 2019